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Abstract
Vc9/Vd2 T cells are a minor subset of T cells in human blood and differ from other T cells by their immediate responsiveness
to microbes. We previously demonstrated that the primary target for Vc9/Vd2 T cells is (E)-4-hydroxy-3-methyl-but-2-enyl
pyrophosphate (HMB-PP), an essential metabolite produced by a large range of pathogens. Here we wished to study the
consequence of this unique responsiveness in microbial infection. The majority of peripheral Vc9/Vd2 T cells shares
migration properties with circulating monocytes, which explains the presence of these two distinct blood cell types in the
inflammatory infiltrate at sites of infection and suggests that they synergize in anti-microbial immune responses. Our
present findings demonstrate a rapid and HMB-PP-dependent crosstalk between Vc9/Vd2 T cells and autologous monocytes
that results in the immediate production of inflammatory mediators including the cytokines interleukin (IL)-6, interferon
(IFN)-c, tumor necrosis factor (TNF)-a, and oncostatin M (OSM); the chemokines CCL2, CXCL8, and CXCL10; and TNF-related
apoptosis-inducing ligand (TRAIL). Moreover, under these co-culture conditions monocytes differentiate within 18 hours
into inflammatory dendritic cells (DCs) with antigen-presenting functions. Addition of further microbial stimuli
(lipopolysaccharide, peptidoglycan) induces CCR7 and enables these inflammatory DCs to trigger the generation of
CD4+ effector ab T cells expressing IFN-c and/or IL-17. Importantly, our in vitro model replicates the responsiveness to
microbes of effluent cells from peritoneal dialysis (PD) patients and translates directly to episodes of acute PD-associated
bacterial peritonitis, where Vc9/Vd2 T cell numbers and soluble inflammatory mediators are elevated in patients infected
with HMB-PP-producing pathogens. Collectively, these findings suggest a direct link between invading pathogens, microbe-
responsive cd T cells, and monocytes in the inflammatory infiltrate, which plays a crucial role in the early response and the
generation of microbe-specific immunity.
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Introduction
The immune system has evolved to survey the body constantly
for potentially hazardous structures. In order to initiate an
appropriate defense, sentinel cells need to encounter ‘danger’
signals derived from invading microbes or stressed tissue [1].
Microbial signals comprise pathogen-associated molecular pat-
terns (PAMPs) that are invariant among a broad range of
organisms, allow self/non-self discrimination, and are detected
by germline-encoded pattern recognition receptors [2,3]. By
contrast to this innate immune recognition, the adaptive immune
response is mediated via somatically rearranged and clonally
distributed antigen receptors on B cells and ab T cells.
Unconventional T cells expressing cd T cell receptors (TCRs)
do not easily fit into this scheme, as they integrate features of
innate and adaptive immune recognition [4–6]. In humans and
higher primates, Vc9/Vd2 T cells comprise a small lymphocyte
population in peripheral blood (typically 0.5–5% of all T cells [7])
that shows a striking propensity for expansion in many infections
[8]. With their unique specificity for the low molecular weight
compound HMB-PP [9], Vc9/Vd2 T cells are specialized in
targeting a distinctive and vital metabolite shared by a broad range
of bacteria (and some protozoan parasites) that is absent in all
higher eukaryotes including humans [10,11]. Selection and
peripheral amplification of public Vc9–Jc1.2 clonotypes during
early childhood appears to ensure rapid, innate-like responses of
Vc9/Vd2 T cells to invading pathogens in later life [12,13].
HMB-PP is 10’000 times more active in vitro than any other
physiological compound [14], and the potential of microbial
pathogens to stimulate Vc9/Vd2 T cells correlates with their ability
to produce HMB-PP [15,16]. Still, Vc9/Vd2 T cells may in vivo also
respond to lower activity agonists such as isopentenyl pyrophosphate
and dimethylallyl pyrophosphate released locally by necrotic host
cells, and may thus alert the immune system to invading pathogens as
well as to tissue damage and progressing tumors [8,17]. Importantly,
HMB-PP and isopentenyl pyrophosphate do not require presentation
by human leukocyte antigen (HLA) class I and II molecules or CD1
[18], supporting a sentinel function of Vc9/Vd2 T cells [19,20].
Activated Vc9/Vd2 T cells display distinct natural killer (NK)
cell-like functions and directly eliminate infected and transformed
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cells, a feature that is successfully being exploited in immunother-
apy trials in cancer patients [21,22]. Another intriguing innate-like
aspect is their potential to act as professional antigen-presenting
cells (APCs), which includes uptake and processing of antigens and
the induction of antigen-specific ab T cell responses [23–25].
However, there is a paucity of data on Vc9/Vd2 T cells from
anatomical locations other than blood and secondary lymphoid
tissue, and information on the response of Vc9/Vd2 T cells in
acute infection is especially sparse, not least due to the absence of
HMB-PP-reactive cd T cells in small animal models [4–6,8].
Studies in severe combined immunodeficiency mice reconstituted
with human peripheral blood mononuclear cells (PBMC) suggest-
ed that Vc9/Vd2 T cell may mediate rapid clearance of
intraperitoneal infections, by enhancing monocyte-mediated
killing of bacteria through production of interferon (IFN)-c and
tumor necrosis factor (TNF)-a [26].
Vc9/Vd2 T cells do not reside at common sites of pathogen
entry, such as skin, lung, gastrointestinal or urinary tract, and it is
unclear under which conditions they are recruited to peripheral
tissues [27]. Infections trigger the local production of inflammatory
chemokines, which control the composition of the cellular infiltrate
[28,29]. Importantly, a change in local chemokines is an essential
factor in the transition from the neutrophil-driven immediate
response to the T and B cell-driven later response to infection. The
majority of circulating Vc9/Vd2 T cells and monocytes expresses
the chemokine receptors CCR2 and CCR5 and displays similar
migration characteristics [27,30–32]. Vc9/Vd2 T cells are thus
well equipped for instant relocation from the circulation and co-
recruitment to inflammatory processes, which explains their
accumulation at sites of infection [33].
We have here examined whether the joined extravasation of
Vc9/Vd2 T cells and monocytes in response to pathogens is of
functional relevance. Our present findings demonstrate a rapid
and HMB-PP-dependent crosstalk between Vc9/Vd2 T cells and
monocytes in the presence of microbes, leading to highly activated
cd T cells on one hand, and to monocyte differentiation into
inflammatory dendritic cells (DCs) on the other hand. This
interaction establishes conditions that support further recruitment
of effector cells in acute infection, enhance local phagocyte
activity, and create antigen-presenting cells (APCs) for the
initiation of microbe-specific adaptive immunity. Importantly,
these events translate directly to episodes of acute bacterial
peritonitis and suggest that cd T cells play a pivotal role in the
immediate response to infection.
Results
Microbe-responsive cd T cells affect monocyte
morphology and survival
Optimum cd T cell stimulation with the microbial metabolite
HMB-PP or related compounds requires the presence of accessory
cells including monocytes [18,34–36]. Here, freshly isolated Vc9/
Vd2 T cells rapidly responded to HMB-PP in the presence of
autologous monocytes as judged by induction of activation
markers and expression of cytokines (data not shown). However,
we noticed that stimulation of Vc9/Vd2 T cells with HMB-PP also
had a pronounced reciprocal effect on the co-cultured monocytes,
and led to cluster formation and the appearance of elongated cells
within 18 hours (Fig. 1A). These spindle-shaped monocytes were
not observed in unstimulated monocyte-cd T cell co-cultures, or in
pure monocyte cultures incubated overnight with HMB-PP or
other bacterial compounds, such as lipopolysaccharide (LPS) or
peptidoglycan (PGN) (Fig. S1A). In addition, this remarkable effect
was also not seen in monocytes treated overnight with granulo-
cyte/macrophage colony-stimulating factor (GM-CSF)+IL-4, a
cytokine combination giving rise to monocyte-derived DCs within
a week of culture [37]; or with macrophage colony-stimulating
factor (M-CSF), which induces differentiation toward macrophag-
es [38] (Fig. S1A). In many cases, monocyte clusters formed
around cd T cells, suggesting their engagement in tight cellular
interactions (Fig. S1B). In support of substantial crosstalk between
these cells, the majority of monocytes survived in co-cultures with
Vc9/Vd2 T cells in the presence of HMB-PP, whereas typically
only ,30% of all monocytes cultured in HMB-PP alone or
together with resting Vc9/Vd2 T cells were still viable after two
days. This ‘conditioning’ with Vc9/Vd2 T cells plus HMB-PP also
resulted in monocyte forward/side scatter profiles that agreed with
the morphologic features seen in the corresponding cultures
(Fig. 1B). Collectively, these data not only confirm that monocytes
provide ‘feeder’ qualities for optimum stimulation of Vc9/Vd2 T
cells with HMB-PP but that they unexpectedly also receive
reciprocal differentiation signals, which are more potent than, and
distinct from, any other in vitro stimulus tested.
Microbe-responsive cd T cells induce monocyte
differentiation into APCs
Next, we examined the phenotypic changes that occurred in
monocytes during overnight co-culture with Vc9/Vd2 T cells and
HMB-PP (abbreviated here as cdHMB-PP). cdHMB-PP-activated
monocytes down-regulated surface CD14 within 18 hours
(Fig. 2A), similarly to monocytes treated with GM-CSF+IL-4 but
unlike monocytes treated with M-CSF (Table S1). At the same
time, HMB-PP-stimulated Vc9/Vd2 T cells induced an up-
regulation of the APC markers CD40, CD86, and HLA-DR on
monocytes, to levels that were comparable, or even superior, to
those seen with GM-CSF+IL-4 or with M-CSF. Importantly,
neither resting Vc9/Vd2 T cells nor HMB-PP alone showed this
activity. Cross-titrations confirmed a highly selective and dose-
dependent effect of HMB-PP-stimulated Vc9/Vd2 T cells on
monocytes. Down-modulation of CD14 was readily observed at an
HMB-PP concentration of 0.1 nM, and at a ratio of 1 cd T cell
per 500 monocytes (Fig. 2B). Induction of APC markers in
monocytes occurred with comparable efficiencies, as illustrated for
CD40. Of note, induction of mRNAs for CD40, CD86, and HLA-
DR in cdHMB-PP-activated monocytes was very rapid and already
Author Summary
As antibiotic resistance is spreading and posing a
significant threat in many bacterial diseases, there is a
need for a better understanding of host responses to
infection. The precise role of an enigmatic subset of
human immune cells, so-called Vc9/Vd2 T cells, in early
infection still remains to be unveiled. These cells respond
to a common molecule shared by the majority of bacterial
pathogens and appear to be quickly drawn to sites of
acute inflammation, where they will encounter invading
microbes in the context of other immune cells, mainly
granulocytes and monocytes. We here observed an
unexpected interplay between microbe-activated Vc9/
Vd2 T cells and monocytes that attracts further effector
cells, enhances the activity of scavenger cells, and
promotes the development of microbe-specific immunity.
These findings not only improve our insight into the
complex cellular interactions in early infection but may
also suggest new therapies by modulating immune
responses to improve host defenses and to resolve
inflammatory activities.
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pronounced after 4.5–6 hours (Fig. 2C). Finally, protein expres-
sion levels for APC markers on cdHMB-PP-activated monocytes
after only 18 hours of co-culture readily exceeded those observed
on fully differentiated monocyte-derived DCs or macrophages
(Fig. 2D). Collectively, these data demonstrate that cdHMB-PP-
activated monocytes undergo a rapid and substantial differentia-
tion program toward an APC phenotype.
The monocyte-cd T cell crosstalk depends on cell-cell
contact
The phenotypic changes seen in cdHMB-PP-activated monocytes
might have stemmed from contact-dependent monocyte-cd T cell
interactions. Hence, we added neutralizing antibodies against
major integrin components to co-cultures, concomitantly with
HMB-PP. Blocking of CD11a or CD18 abrogated morphologic
changes and cluster formation, while antibodies against CD11b or
CD49d showed no such effect (Fig. 3A), indicating a crucial
involvement of lymphocyte function-associated antigen-1 (LFA-1,
CD11a/CD18) but not macrophage antigen-1 (Mac-1, CD11b/
CD18) or very late antigen-4 (VLA-4, CD49d/CD29). As a
consequence of broken cell clusters, monocytes were not
transformed into APCs in the absence of LFA-1 contacts, since
anti-CD11a and anti-CD18, but not anti-CD11b or anti-CD49d,
antibodies inhibited CD14 down-modulation, and up-regulation
of CD40 and CD86 (Fig. 3B). Collectively, these data demonstrate
that the morphological changes and the rapid acquisition of APC
markers by monocytes require cell-cell interactions, leading to
activation of Vc9/Vd2 T cells in the presence of HMB-PP and
reciprocal activation of monocytes.
Microbe-responsive cd T cells induce monocyte
differentiation through cytokines
The possible contribution of soluble factors was examined in
transwell experiments by measuring the response of monocytes in
the lower chamber to molecules released by monocyte-cd T cell
co-cultures in the upper chamber. In this setting, HMB-PP-
stimulated but not unstimulated co-cultures produced soluble
factors that crossed the separating membrane and down-
modulated CD14 as well as induced expression of CD40, CD86,
and HLA-DR. These factors included IFN-c and TNF-a, since
addition of neutralizing antibodies against IFN-c and soluble
TNF-a receptor (sTNFR) reversed the effects on CD14 and CD40
expression in transwell cultures (Fig. S2; and data not shown). We
corroborated these findings in HMB-PP-stimulated monocyte-cd
T cell co-cultures, where addition of anti-IFN-c and sTNFR, but
not anti-GM-CSF or anti-IL-4, inhibited morphologic changes
and monocyte survival (Fig. 4A; Fig. S2). cd T cell-derived IFN-c
and TNF-a also appeared to be the major regulators of cell surface
CD14, CD40, and CD86 expression, whereas GM-CSF and IL-4
had only minor effects (Fig. 4B). Still, a cocktail of blocking
Figure 1. Vc9/Vd2 T cells promote monocyte survival and morphological changes. (A) Microscopic analysis of monocytes co-cultured for
18 hours with cd T cells in the absence or presence of HMB-PP, representative of three individual donors. (B) Flow cytometric analysis of freshly
isolated monocytes, or monocytes cultured in the presence of HMB-PP, cd T cells, or cd T cells+HMB-PP for 42 hours. Data shown are forward and
side scatters of all CD3-negative cells, and are representative of three individual donors.
doi:10.1371/journal.ppat.1000308.g001
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reagents against IFN-c, TNF-a, IL-4, and GM-CSF inhibited the
cd T cell-induced down-modulation of CD14 and up-regulation of
CD40 and CD86 on monocytes more than just the combination of
anti-IFN-c+sTNFR (Fig. S3). Of note, both recombinant IFN-
c+TNF-a and GM-CSF+IL-4 promoted cell survival in pure
monocyte cultures, down-modulated CD14, and induced APC
marker expression.
In addition to CD40, CD86, and HLA-DR, cdHMB-PP-activated
monocytes expressed CD83, CD206 (mannose receptor) and
CD209 (DC-SIGN) (Fig. 4C), while CD205 (DEC-205) and
CD207 (langerin) were absent (Table S1). Of note, GM-CSF+IL-4
but not IFN-c+TNF-a mimicked the effect of HMB-PP-stimulated
Vc9/Vd2 T cells on CD206 and CD209 expression in pure
monocytes (Fig. S4), and anti-GM-CSF+anti-IL-4 blocked the cd
T cell-induced expression of CD206 and CD209 in co-cultures
(Fig. 4C). Neutralization of IFN-c and TNF-a increased the levels
of CD206 and CD209 even further, in line with reports showing
that acquisition of ‘classical’ DC markers such as CD1a and
CD209 by monocytes is dependent on IL-4 and counteracted by
IFN-c [39]. Collectively, these data demonstrate that the rapid
acquisition of DC-like features by monocytes is mediated in part
through the HMB-PP-driven release of IFN-c, TNF-a, GM-CSF,
and IL-4 by Vc9/Vd2 T cells.
Microbe-responsive cd T cells induce rapid expression of
inflammatory mediators in monocytes
Microbial sensing by DCs induces the release of a plethora of
factors, the combination of which reflects the type of the
Figure 2. Vc9/Vd2 T cell-activated monocytes acquire APC markers. (A) Mean fluorescence intensity (MFI)6SEM of CD14, CD40, CD86, and
HLA-DR for monocytes after 18 hours of culture under the conditions indicated (n$4). (B) MFI6SD of CD14 (top) and CD40 (bottom) for monocytes
co-cultured with cd T cells at various ratios in the presence of 10 nM HMB-PP (left panels), or with cd T cells at a ratio of 5:1 in the presence of
different concentrations of HMB-PP (right panels), as analyzed after 18 hours in triplicate. (C) Mean mRNA expression levels of CD40, CD86, and HLA-
DRa from duplicate measurements for activated monocytes and cd T cells sorted after 4.5–6 hours from co-cultures in the presence of HMB-PP,
compared with control cells sorted from co-cultures in the absence of HMB-PP (top panels), or with freshly isolated, resting monocytes and cd T cells
(bottom panels). (D) MFI6SEM of CD40, CD86, and HLA-DR for freshly isolated monocytes (mono) and monocytes co-cultured with cd T cells and
HMB-PP for 18 hours, in comparison with fully differentiated immature DCs (iDC), LPS-matured DCs (mDC), and macrophages (mw) (n= 3–6).
doi:10.1371/journal.ppat.1000308.g002
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encountered microorganism and the quality of the T cell response
required for the control of this particular pathogen. We therefore
examined the cytokine profile of cdHMB-PP-activated monocytes.
Addition of HMB-PP to monocyte-cd T cell co-cultures not only
induced TNF-a production in cd T cells (data not shown), it also
led to expression of significant levels of TNF-a in co-cultured
monocytes (Fig. 5A). TNF-a mRNA was rapidly induced in
cdHMB-PP-activated monocytes and abundantly present after 4.5–
6 h, at levels even exceeding those in the co-cultured cd T cell
population (Fig. 5B). Similarly as described above for CD14 and
APC markers, TNF-a expression was highly dependent on the
concentration of HMB-PP and the number of cd T cells in the co-
cultures (Fig. 5C). These data suggest a positive feed-back
mechanism in the inflammatory response, where both monocytes
and cd T cells rapidly produce large amounts of TNF-a.
Two other inflammatory cytokines expressed by cdHMB-PP-
activated monocytes were IL-6 and oncostatin M (OSM), which
were detectable in the supernatants of HMB-PP-stimulated co-
cultures (Fig. 5D); IL-6 was confirmed to be expressed in
monocytes by intracellular staining (data not shown). Expression
of TNF-a and IL-6 but not OSM by cdHMB-PP-activated
monocytes could be blocked by anti-IFN-c+sTNFR (Fig. 5A,
5D), and mimicked by addition of recombinant IFN-c+TNF-a to
pure monocyte cultures (data not shown). By contrast, the same
monocyte-cd T cell co-culture conditions did not lead to induction
of IL-1b, IL-10, IL-12, IL-23, or IL-27, as assessed by protein
Figure 3. Monocyte-cd T cell crosstalk depends on cell-cell contract. (A) Microscopic analysis of co-cultures of monocytes and cd T cells
incubated for 18 hours in the presence of HMB-PP and the neutralizing antibodies indicated. Data shown are representative of two individual donors.
(B) Mean inhibitory effect6SEM of blocking antibodies on CD14 down-regulation, and CD40 and CD86 up-regulation. 0%, monocyte-cd T cell co-
cultures with HMB-PP in the absence of blocking antibodies; 100%, monocytes cultured in medium only (n= 4–5).
doi:10.1371/journal.ppat.1000308.g003
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and/or mRNA expression analyses (Table S1). Intriguingly,
although cdHMB-PP-activated monocytes expressed high levels of
CD40, engagement of this receptor by soluble trimeric CD40L did
not result in detectable levels of IL-12 or IL-23 but led to the
release of substantial amounts of IL-6 (data not shown). Finally,
neither HMB-PP-stimulation of monocyte-cd T cell co-cultures
nor treatment of monocytes with recombinant IFN-c and/or
TNF-a was able to induce significant levels of nitric oxide in
monocytes (data not shown) [40]. However, these co-culture
conditions led both cd T cells (data not shown) and monocytes
(Fig. 5D) to express the pro-apoptotic effector molecule TNF-
related apoptosis inducing ligand (TRAIL) [41]. Collectively, these
data demonstrate that crosstalk of monocytes and HMB-PP-
stimulated cd T cells leads to the rapid generation of a highly
inflammatory milieu.
Microbe-responsive cd T cells change the migratory
profile of monocytes
The function of APCs is largely governed by their recruitment
and relocation properties. Of note, HMB-PP-stimulated mono-
cyte-cd T cell co-cultures were a rich source of chemokines with
known functions in acute infections, as shown for CXCL8 (IL-8)
and CCL2 (MCP-1), which target neutrophils and monocytes,
respectively, and CXCL10 (IP-10), one of three IFN-c-inducible
chemokines that control the recruitment of effector T cells. All
three chemokines were rapidly induced in monocyte-cd T cell co-
cultures in the presence of HMB-PP and could be blocked by anti-
IFN-c+sTNFR (Fig. 6A).
Circulating monocytes express a series of chemokine receptors,
including CXCR4 and the prototype monocyte receptors CCR2
and CCR5 [28]. Here, cdHMB-PP-activated monocytes down-
modulated surface expression of CXCR4, CCR2, and CCR5
(Fig. 6B; and data not shown), which may have resulted from
chemokine-mediated receptor internalization [42]. Intriguingly,
the chemokine receptor CCR7, which enables mature DCs and
naı¨ve T cells to co-localize within the T-zone of lymph nodes, was
not induced under these conditions (Fig. 6B) but was readily
detected when further microbial stimuli such as LPS (Fig. 6C) or
PGN (not shown) were added to HMB-PP-stimulated monocyte-
cd T cell co-cultures. Collectively, these data demonstrate that
cdHMB-PP-activated monocytes produce cytokines and chemokines
typically associated with inflammatory sites but lack factors such as
CCR7 that are mobilized in response to Toll-like receptor (TLR)
ligands. The chemokine profile of cdHMB-PP-activated monocytes
and their capacity to switch from inflammatory chemokine
receptors to CCR7 is reminiscent of immature DCs undergoing
maturation and acquisition of lymph node homing properties [43].
cdHMB-PP-activated monocytes present microbial antigens
to ab T cells
The resemblance of cdHMB-PP-activated monocytes with
inflammatory DCs prompted us to examine their ability to present
Figure 4. Monocyte-cd T cell crosstalk depends on soluble mediators. (A) Mean percentage6SEM of surviving monocytes co-cultured with
cd T cells without or with HMB-PP, or with HMB-PP and anti-IFN-c+sTNFR (n= 3), in relation to the starting numbers of monocytes in the cultures
( = 100%). (B) Mean inhibitory effect6SEM of the blocking reagents indicated on CD14 down-regulation, and CD40 and CD86 up-regulation. 0%,
monocyte-cd T cell co-cultures with HMB-PP in the absence of blocking antibodies; 100%, monocytes cultured in medium only (n= 4–5). (C)
MFI6SEM of CD83, CD206 and CD209 for monocytes after 18 hours of culture under the conditions indicated (n= 3–5).
doi:10.1371/journal.ppat.1000308.g004
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Figure 5. Vc9/Vd2 T cell-activated monocytes produce inflammatory mediators. (A) Mean percentages6SEM of TNF-a+ monocytes after
18 hours of culture under the conditions indicated (n= 3–7). (B) Mean mRNA expression levels of TNF-a from duplicate measurements for activated
monocytes and cd T cells sorted after 4.5–6 hours from co-cultures in the presence of HMB-PP, compared with control cells sorted from co-cultures in
the absence of HMB-PP (left), or with freshly isolated, resting monocytes and cd T cells (right). (C) Mean percentages6SD of TNF-a+ monocytes co-
cultured with cd T cells at various ratios in the presence of 10 nM HMB-PP (left), or with cd T cells at a ratio of 5:1 in the presence of different
concentrations of HMB-PP (right), as analyzed after 18 hours in triplicate cultures. (D) Mean protein levels (pg/ml)6SEM of secreted IL-6 and OSM, and
mean percentages6SEM of TRAIL+ monocytes after 18 hours of culture under the conditions indicated (n= 3–7).
doi:10.1371/journal.ppat.1000308.g005
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Figure 6. Vc9/Vd2 T cell-activated monocytes possess altered migratory properties. (A) Mean protein levels (pg/ml)6SEM of secreted
CCL2, CXCL8, and CXCL10, and (B) mean percentages6SEM of CXCR4+, CCR2+, and CCR5+ monocytes after 18 hours of culture under the conditions
indicated (n= 3–8). (C) Side scatter and CCR7 fluorescence for monocytes after 18 hours of culture in medium, or with cd T cells+HMB-PP in the
absence or presence of LPS; representative of two independently assessed donors.
doi:10.1371/journal.ppat.1000308.g006
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antigens and induce ab T cell activation. First, we established that
monocytes co-cultured with cd T cells retained endocytic
activities, as assessed by uptake of soluble proteins, Lucifer yellow
and dextran, and phagocytosis of bacteria (data not shown). These
experiments ruled out the presence of inhibitory factors associated
with DC maturation. Next, we studied the activation of ab T cells
in response to autologous monocytes presenting Mycobacterium
tuberculosis purified protein derivative (PPD), which requires uptake
and processing, and Staphylococcus aureus superantigen toxic shock
syndrome toxin-1 (TSST-1), which is loaded directly onto cell
surface HLA class II [23].
cdHMB-PP-activated monocytes induced a significant expansion
of PPD-specific T cells from 5-(and 6-)carboxyfluorescein diacetate
succinimidyl ester (CFSE)-labeled, naı¨ve responder ab T cells, as
evidenced by the appearance of proliferating CD45RO+ ab T cells
after only 4 days of culture; this ab T cell expansion was not seen
in the presence of freshly isolated monocytes or monocytes co-
cultured with resting Vc9/Vd2 T cells (Fig. 7A). Of note,
neutralization of IFN-c and TNF-a during co-culture of
monocytes with HMB-PP-stimulated Vc9/Vd2 T cells prevented
this response, which fully agrees with the observed inhibition of
APC marker expression (Fig. 4). Similarly, cdHMB-PP-activated
monocytes served as APCs for the expansion of TSST-1-specific
CD45RO+ Vb2+ cells from CFSE-labeled, naı¨ve responder ab T
cells (data not shown). Generation of TSST-1-specific ab T
effector cells was very robust when using cdHMB-PP-activated
monocytes as APCs, as evidenced by the large proportion of IFN-
c-producing Vb2+ T cells, but was largely absent with control
monocytes (Fig. 7B). As opposed to IFN-c, IL-17 was not induced
in TSST-1-specific responder T cells by cdHMB-PP-activated
monocytes, whereas cdHMB-PP-activated monocytes treated with
LPS or PGN were able to do so (Fig. 7B; and data not shown),
confirming that TLR ligands have a direct impact on the
generation of microbe-specific Th17 cells [44]. Collectively, these
data suggest that monocytes turn into Th1 cell-inducing
inflammatory DCs in the presence of HMB-PP-stimulated Vc9/
Vd2 T cells and possess the capacity for further development into
lymph node seeking (CCR7+) Th17 cell-inducing DCs upon
contact with microbes via TLR signaling.
Microbe-responsive cd T cells are present in the
peritoneal cavity and are potent inducers of monocyte
differentiation
In order to extend our study to situations of disease, we
examined peritoneal effluent cells from individuals on continuous
ambulatory peritoneal dialysis (PD) (Table S2), where bacterial
infection and associated inflammation remain a frequent compli-
cation. The peritoneal catheter of PD patients allows convenient,
repeated, and non-invasive sampling of recruited leukocytes, and
provides unique access to inflammatory scenarios in vivo [45].
Under stable, i.e. non-inflamed conditions, peritoneal effluent
cells consisted mainly of CD3+ lymphocytes and CD14+
monocytes. Importantly, Vc9/Vd2 T cells represented a minor
but detectable fraction of peritoneal leukocytes (0.06–0.28%). As
these values were similar to the activation threshold in our titration
experiments with peripheral monocyte-cd T cell co-cultures
(Fig. 2B), we tested whether peritoneal cd T cells interact with
peritoneal monocytes in a similar way. Indeed, addition of HMB-
PP led to cluster formation and the appearance of larger, activated
cells within 18 hours. This morphological change was significantly
inhibited by anti-IFN-c+sTNFR or anti-CD11a+anti-CD18
neutralizing antibodies (Fig. S5A). The Vc9/Vd2 T cells in these
peritoneal cultures showed a dose-dependent response to HMB-PP
that was already apparent at 0.1 nM, as judged by expression of
CD25, CD69, and TNF-a (Fig. S5B). Moreover, HMB-PP at
concentrations of .10 nM led to expansion of Vc9/Vd2 T cells
(i.e., in the absence of exogenously added cytokines) (Fig. S5B). In
the same cultures, monocytes showed a corresponding dose-
dependent response to HMB-PP at 0.1 nM and higher, as judged
by increased forward scatter, down-modulation of CD14, up-
regulation of CD40 and CD86, and induction of TRAIL and
TNF-a (Fig. S5C). Collectively, these data demonstrate that Vc9/
Vd2 T cells are present in the peritoneal cavity and able to induce
rapid monocyte differentiation in the presence of minute quantities
of HMB-PP.
cd T cell numbers and soluble inflammatory mediators
are elevated in HMB-PP+ bacterial peritonitis
In addition to the situation in non-infected individuals, Vc9/
Vd2 T cells were also detectable during episodes of PD-associated
bacterial peritonitis. As expected from early stage infections,
neutrophils represented the vast majority of peritoneal cells, while
the number of Vc9/Vd2 T cells varied considerably (from
,0.01% up to 7.3% of total leukocytes) and could amount to
several million cells in the over-night effluent (Fig. 8A). Compared
to stable, non-infected controls, the proportion of Vc9/Vd2 T cells
among peritoneal CD3+ T cells and among total peritoneal
effluent cells was considerably augmented in patients with acute
peritonitis as a result of infection with the HMB-PP+ bacteria E.
coli, Leclercia, or Bacteroides (Fig. 8A). This was not the case in
patients infected with HMB-PP2 staphylococci or streptococci,
which confirms in vivo that human Vc9/Vd2 T cells selectively
recognize microbial pathogens capable of synthesizing HMB-PP
(Table S3) [8–11,14–16].
Peritoneal Vc9/Vd2 T cell frequencies and CD69 expression
levels in HMB-PP+ peritonitis patients were consistently higher
than in the peripheral blood of the same patients (data not shown),
implying local recruitment/proliferation and activation in the
peritoneal cavity. In addition, highest numbers of activated,
CD69+ Vc9/Vd2 T cells were seen at the earliest time-points post-
infection (p.i.) and steadily declined over the following days to the
background values seen in HMB-PP2 bacterial infections and in
non-infected individuals (Fig. 8A), underscoring an immediate as
opposed to long-lasting involvement of HMB-PP-responsive cd T
cells in bacterial infections.
Finally, we examined peritoneal effluent for the presence of a
series of soluble factors (IL-6, TNF-a, TRAIL, CXCL10, and
OSM) that we found prominently expressed in HMB-PP-
stimulated monocyte-cd T cell co-cultures. Remarkably, all five
proteins could be detected in patients samples and were higher in
HMB-PP+ infections (E. coli, Neisseria, Proteus, Pseudomonas,
unspecified coliform and coryneform bacteria) than in HMB-
PP2 staphylococcal or streptococcal infections on day 1 p.i.
(Fig. 8B; 9.75 and 7.38 pg/ml OSM, n.s.). Moreover, and in
agreement with the gradual reduction in peritoneal cd T cell
numbers, cytokine levels similarly declined over the following days
p.i. (Fig. 8C; and data not shown). Collectively, these data imply
that Vc9/Vd2 T cells play a significant role in PD-associated acute
infection caused by HMB-PP+ producing pathogens.
Discussion
We have employed an in vitro model, composed of autologous
Vc9/Vd2 T cells, monocytes, and the microbial metabolite HMB-
PP, that mimics local conditions at early stage infections while
leaving out components of the immediate (neutrophils) and
adaptive (T and B cells) immune response. We hypothesized that
our model would shed light on the role of Vc9/Vd2 T cells in the
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control of anti-microbial immunity. Our present findings demon-
strate a reciprocal interaction between cd T cells and monocytes
within 18 hours, leading to the rapid induction of a remarkable
differentiation program in monocytes. The cd T cell-mediated
effects on monocytes included enhanced survival; production of
inflammatory cytokines and chemokines; and the development of
DC-like characteristics, as evidenced by morphologic features,
expression of APC markers, uptake and processing of antigens,
Figure 7. Vc9/Vd2 T cell-activated monocytes present bacterial antigens to autologous ab T cells. (A) Freshly isolated monocytes, or
activated monocytes generated for 18 hours under the conditions indicated were used as APCs and incubated with CFSE-labeled naı¨ve ab T cells in
the presence of PPD. CFSE dilution and CD45RO expression was measured after a further 96 hours of culture. Dot plots are gated on total CD3+ T
cells; numbers indicate the percentage of CFSElo CD45RO+ T cells. (B) Freshly isolated monocytes, or activated monocytes generated as above were
loaded with TSST-1 and used as APCs for ab T cells. Intracellular cytokine expression in responder T cells was measured after 72 hours of culture. Dot
plots are gated on total CD3+ T cells; numbers indicate the percentage of Vb2+ T cells expressing IFN-c. No cytokine expression occurred in the
absence of TSST-1. (C) IFN-c and IL-17 production by naive CD4+ T cell cultures in the presence of TSST-1-pulsed freshly isolated monocytes or
monocytes pre-treated under the conditions indicated, as detected after 72 hours by intracellular staining for IFN-c (gated on TCR-Vb2+ T cells) and
ELISA for IL-17. Data in A–C are representative of two experiments performed.
doi:10.1371/journal.ppat.1000308.g007
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Figure 8. Peritoneal Vc9/Vd2 T cells and Vc9/Vd2 T cell-induced proteins are increased in HMB-PP+ peritonitis. (A) Frequencies of Vc9+
T cells among CD3+ lymphocytes (top panel) and total leukocytes (middle panel), and absolute numbers of CD69+ Vc9+ T cells (bottom panel), as
determined in non-infected individuals (n= 5–7), and patients with HMB-PP+ (Bacteroides splanchnicus, E. coli, Leclercia adecarboxylata, Proteus
vulgaris) (n= 5) or HMB-PP2 peritonitis (Staphylococcus epidermidis, a-hemolytic Streptococcus spp.) (n= 8–13). (B) Peritoneal cytokine levels6SEM on
day 1 p.i., and (C) time course of CXCL10 levels over 6 days p.i. in cell-free effluent fluid from patients with HMB-PP+ (E. coli, Neisseria sp., Proteus sp.,
Pseudomonas sp., unspecified coliform and coryneform bacteria) (n= 7–10) or HMB-PP2 peritonitis (Staphylococcus aureus, Staphylococcus epidermidis,
a-hemolytic Streptococcus spp.) (n= 13–16).
doi:10.1371/journal.ppat.1000308.g008
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and induction of antigen-specific ab T cell responses. Of note,
these inflammatory DCs were not generated when HMB-PP was
omitted from the monocyte-cd T cells co-cultures, illustrating the
importance of TCR-triggering in cd T cells for initiation of
monocyte differentiation. Also, these changes in monocytes did not
require the addition of exogenous cytokines and occurred within
18 hours, in contrast to what was previously reported in co-
cultures with NK cells or NKT cells [46,47]. While the
mechanisms of driving monocyte differentiation toward DCs
may be similar between cd T cells and NK cells and involve the
same factors, in those studies co-culture periods of up to 6 days
with IL 15-activated NK cells or excess cloned NKT cells were
required. In our own experiments, we observed an intimate and
rapid monocyte-cd T cell crosstalk that occurred within a few
hours, at subnanomolar HMB-PP concentrations, and at ratios as
low as 1 cd T cell per monocyte. These conditions resemble early
stages of infections where monocytes outnumber cd T cells, and
where low numbers of bacteria produce trace amounts of HMB-
PP. Of note, we previously estimated lysates of E. coli [48] and L.
monocytogenes [16] bacterial cells to contain 200–300 nM HMB-PP.
Thus, we conclude that our experimental setup adequately mirrors
an early aspect in acute anti-microbial defense and implies a role
for inflammatory DCs, generated by short-term culture of
monocytes in the presence of Vc9/Vd2 T cells and HMB-PP, in
pathogen clearance and induction of microbe-specific T cell
responses. At the same time, activated Vc9/Vd2 T cells may
acquire APC features themselves and contribute to the transition
from the innate to the adaptive phase of the immune response
[23–25].
The pronounced effect of the microbial metabolite HMB-PP on
Vc9/Vd2 T cells at low nanomolar concentrations is remarkable
but remains elusive. Possible scenarios include direct binding of
HMB-PP to the TCR, alone or in the context of a ‘presenting’
molecule on accessory cells, or the generation of a secondary Vc9/
Vd2 T cell-specific ligand in response to HMB-PP [49–52]. Also, it
is not clear if invading pathogens release free HMB-PP into the
microenvironment, or whether HMB-PP becomes only accessible
upon processing of bacteria by phagocytic cells. Studies with the
intracellular pathogen Mycobacterium tuberculosis suggest that uptake
of whole bacteria by monocytes, macrophages, or DCs is required
for the recognition of HMB-PP, highlighting an essential role for
monocytic cells in the activation of Vc9/Vd2 T cells [53–55]. It is
conceivable that neutrophils, which are the first cells to be
mobilized in response to bacterial infections, may also contribute
to Vc9/Vd2 T cell activation. Irrespective of the underlying
mechanism, the extremely potent yet highly selective activation of
Vc9/Vd2 T cells by a single microbial compound is reminiscent of
bona fide PAMPs and other ‘danger’ signals that our innate immune
system has learnt to recognize in order to mount robust anti-
microbial responses [1–3].
The generation of inflammatory DCs during co-culture with
HMB-PP was the result of a combination of direct cell-cell contact
and cytokines released by activated cd T cells. Macroscopic
changes in the co-cultures included LFA-1-dependent cell
clustering as well as polarized monocyte spreading, and inhibition
of integrin function prevented the formation of inflammatory DCs,
in agreement with the role of LFA-1 in conjugate formation
between cd T cells and other cells [18,56]. Transwell assays and
experiments with neutralizing antibodies revealed the importance
of Vc9/Vd2 T cell-derived soluble factors in monocyte activation,
foremost IFN-c, TNF-a, GM-CSF, and IL-4, which are co-
expressed by the same Vc9/Vd2 T cell population upon
stimulation with HMB-PP [36]. However, no cytokine combina-
tion fully substituted for HMB-PP-stimulated Vc9/Vd2 T cells,
and complete inhibition was not achieved with a cocktail of
blocking reagents against IFN-c, TNF-a, GM-CSF, and IL-4,
implying additional soluble and/or cell-associated components in
promoting monocyte activation, including IL-13, CD40L, and
integrin ligands [31,36]. Thus, we conclude that HMB-PP-
stimulated Vc9/Vd2 T cells are perfectly equipped to interact
with monocytes by providing a whole range of factors necessary
for monocyte survival and differentiation into inflammatory DCs.
Clearly, these findings differ from the reported effect of cd T cell-
derived IFN-c and TNF-a on monocyte-mediated killing of
bacteria [26] or on the maturation of immature DCs [55,57–59].
The overall outcome of our in vitro co-cultures was a milieu rich
in inflammatory mediators that gave rise to cells with character-
istics of immature DCs. We did not detect IL-1b, IL-12, IL-23, or
IL-27 in the culture supernatants, a fact that may be explained by
the absence of TLR ligands or other ‘danger’ signals. Despite
uniform expression of CD40 on cdHMB-PP-activated monocytes,
signaling through this receptor by means of co-culture with
CD40L+ Vc9/Vd2 T cells or activation with soluble CD40L did
not lead to substantial levels of IL-12 or IL-23, further
documenting the paramount importance of synergism with
microbial products [60]. The inflammasome-controlled processing
of IL-1b is induced by numerous microbial ligands [61], and the
absence of IL-1b (and IL-23) in our co-cultures could explain the
observed inability of inflammatory DCs to induce the differenti-
ation of naı¨ve ab T cells into Th17 cells [44]. In agreement, we
were able to ‘correct’ this deficit by adding LPS or PGN to our co-
cultures, which resulted in inflammatory DCs capable of inducing
Th17 cells. Finally, the lymph node homing receptor CCR7 was
completely absent in inflammatory DCs but became expressed
upon treatment with LPS or PGN. We therefore conclude that our
co-culture system allows a view at the cellular cross-talk between
two types of simultaneously recruited immune cells that occurs in
the absence of TLR signaling. This model will be useful for
studying the parameters that determine the ‘quality’ of microbe-
specific ab T cell responses (Th1, Th2, Th17, Tfh, Treg) by
treating inflammatory DCs with defined microbial compounds or
whole pathogens.
It is conceivable that our model of cdHMB-PP-induced
inflammatory DCs is more relevant to induction of adaptive
immunity in response to acute infections as opposed to monocyte-
derived DCs that require one week of in vitro culture for
development [37]. Recent studies in mice provided compelling
evidence that circulating monocytes are able to develop into DCs
in vivo [62,63]. Murine Gr-1+ CCR2+ monocytes (which
correspond to the CD14high human blood monocytes used in the
present study) are recruited to sites of infection where they
differentiate into inflammatory DCs [64,65]. The factors respon-
sible for the conversion of blood monocytes into DCs in humans
and the kinetics by which they act are largely unknown, where
access to tissue material at early stage infections is limited.
Evidently, inflammatory chemokines, e.g. those produced under
the settings of bacterial invasion, will selectively recruit blood
monocytes expressing the corresponding chemokine receptors
while factors provided by local tissue-resident cells and microbes
will affect survival and differentiation of recruited monocytes.
The powerful monocyte-cdT cell crosstalk reported here translates
directly to episodes of bacterial peritonitis. Our data demonstrate that
Vc9/Vd2 T cells in peritonitis patients infected with HMB-PP+
bacterial species were always highest at the earliest time points when
infected peritoneal samples could be retrieved (day 1–2 p.i.), and then
gradually declined over the next few days. In contrast, Vc9/Vd2 T
cell frequencies and total numbers in patients infected with HMB-
PP2 bacterial species did not vary from the stable, non-inflamed
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situation, and remained constant over the course of one week after
the onset of infection. Most remarkably, this initial peak and rapid
resolution of Vc9/Vd2 T cell numbers in HMB-PP+ peritonitis
clearly preceded the delayed influx of ab T cells (day 3–4 p.i.) yet
overlapped with the early wave of neutrophils (day 1–2 p.i.) that was
observed previously in PD-associated peritonitis patients [45,66–68].
An attractive hypothesis would predict that some of the mediators we
identified in our in vitro model control neutrophil recruitment and
function (IFN-c, IL-6, OSM) [66,67] as well as neutrophil turnover
(TRAIL) [69]. Accordingly, we could demonstrate that responses to
HMB-PP of unfractionated peritoneal cells were indistinguishable
from those seen in our in vitro model, as evidenced by cytokine
production (including IFN-c, TNF-a, and TRAIL) and induction of
APC markers on monocytes. Thus, Vc9/Vd2 T cells are ideally
positioned to contribute to immediate infection control and to
support microbe-specific adaptive immune responses in patients with
HMB-PP+ bacterial infections. Ongoing studies are designed to
examine the monocytic infiltrate and DC subsets in acute bacterial
peritonitis and detect phenotypic and functional differences between
HMB-PP+ and HMB-PP2 infections. Of note, disproportionate
monocyte-cd T cell crosstalk may result in excessive production of
inflammatory mediators, possibly explaining why episodes of HMB-
PP+ peritonitis are associated with a 2–3fold increased risk of PD
technique failure (removal of the peritoneal catheter, transfer to
hemodialysis, and/or patient death) and implying a role for cdT cells
in the nature and severity of the inflammatory response to pathogens
(our unpublished observations).
In summary, our in vitro and ex vivo data support a model where
Vc9/Vd2 T cells bridge innate and adaptive immune mechanisms
in response to infection with HMB-PP-producing pathogens. At
the earliest stage of infection, microbial products activate local
macrophages and tissue cells to produce neutrophil-specific
(CXCL8 and related chemokines) and monocyte/cd T cell-
specific chemokines (CCL2-5) [70]. Freshly recruited Vc9/Vd2 T
cells interact with monocytes and become activated by microbial-
derived HMB-PP, which in turn leads to substantial cytokine
secretion and the generation of inflammatory DCs. Following
antigen-uptake and processing, newly generated DCs upregulate
CCR7 in response to microbes, and relocate to the draining lymph
nodes where they instruct microbe-specific effector T cells. Thus,
Vc9/Vd2 T cells set the stage for early adaptive immune responses
while invading microbes determine the choice of play.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki and under local ethical guidelines
(Bro Taf Health Authority, Wales). The study was approved by the
South East Wales Local Ethics Committee under reference
number 04WSE04/27. All patients provided written informed
consent for the collection of samples and subsequent analysis.
Patients
43 patients on PD for #5 years were recruited from the
Peritoneal Dialysis Unit, Cardiff University School of Medicine
(Table S2). Diagnosis of acute peritonitis was based on the presence
of abdominal pain, a cloudy peritoneal effluent with .105
leukocytes per ml, and a positive microbiological culture. The day
of the first appearance of leukocytes in the effluent was defined as
day 1 post-infection. The causative organisms of bacterial peritonitis
were divided into HMB-PP2 (Enterococcus, Staphylococcus, Streptococcus)
and HMB-PP+ species (Bacteroides, Corynebacterium, Escherichia,
Leclercia, Neisseria, Proteus, Pseudomonas, and other coliform or
coryneform bacteria), in accordance with the distribution of the
non-mevalonate pathway of isoprenoid biosynthesis across their
genomes (Table S3) [8,11]. Patients with bacterial episodes of
peritonitis were uniformly treated with a standard regime of
ciprofloxacin and vancomycin according to the guidelines of the
International Society for Peritoneal Dialysis (ISPD).
Cell isolation
Peritoneal cells were harvested from chilled overnight dwell
effluents [45]; cell-free supernatants were stored at 270uC. PBMC
were isolated from peripheral blood using Lymphoprep (Axis-
Shield). Monocytes (.99%) were purified from PBMC of healthy
volunteers using anti-CD14 microbeads (Miltenyi). Vc9/Vd2 T
cells (99.0460.65% Vc9+, mean6SD) were purified from CD14-
depleted PBMC using monoclonal antibodies (mAbs) against Vc9-
PE-Cy5 (Immu360; Beckman-Coulter) and anti-PE microbeads
(Miltenyi). Untouched bulk ab T cells (.95%) and naı¨ve CD4+ T
cells (.95%) were purified from cd T cell-depleted PBMC using
the pan-T cell isolation kit II and the naı¨ve CD4+ T cell isolation
kit (Miltenyi), respectively. Immature DCs were derived from
monocytes over 6 days in 50 ng/ml GM-CSF and 10 ng/ml IL-4
(Peprotech); mature DCs were obtained from DCs by adding
100 ng/ml LPS (Sigma) for 15 h. Macrophages were derived from
monocytes over 6 days in 50 ng/ml M-CSF (Peprotech).
Flow cytometry
Cells were analyzed on a four-color FACSCalibur supported
with CellQuest (BD Biosciences), using mAbs against pan-TCRcd
(11F2), TCR-Vd2 (B6.1), CD3 (SK7, UCHT1, HIT3a), CD4
(RPA-T4), CD14 (MOP9), CD25 (M-A251), CD45RA (HI100),
CD45RO (UCHL-1), CD69 (FN50), CD83 (HB15e), CD86
(2331), HLA-DR (L243), CCR5 (2D7), and CXCR4 (12G5) (all
from BD Biosciences); TCR-Vb2 (MPB2D5), TCR-Vc9
(Immu360), CD40 (mAB89), CD206 (3.29B1.10), and CD207
(DCGM4) from Beckman Coulter; CD209 (120507) and CCR2
(48607.211) from R&D Systems; CD205 (DEC-205) from
eBioscience; TCR-Vd1 (TS8.2) from Endogen; and rat anti-
CCR7 (3D12) from Dr. M. Lipp (Max Delbru¨ck Center for
Molecular Medicine, Berlin, Germany); together with appropriate
isotype controls and secondary reagents. For detection of
intracellular cytokines, brefeldin A (Sigma) was added to cultures
at 10 mg/ml 4 hours prior to harvesting. Surface-stained cells were
labeled using the Fix&Perm kit (eBioscience) and mAbs against
IFN-c (45.15), TRAIL (RIK-2) (BD Biosciences), TNF-a (188)
(Beckman Coulter), IL-6 (AS12), IL-10 (JES3-9D7), and IL-17
(64DEC17) (eBioscience). Monocytes in co-cultures were identified
based on their appearance in forward/sideward scatter, lack of
CD3 expression and residual expression of CD14; cd T cells were
gated on CD3+ Vc9+ lymphocytes.
Monocyte cultures
The medium used was RPMI-1640 with 2 mM L-glutamine,
1% non-essential amino acids, 1% sodium pyruvate, 50 mg/ml
penicillin/streptomycin, 50 mM b-mercaptoethanol, and 10%
fetal calf serum (Invitrogen). Monocytes were co-cultured with
cd T cells at a ratio of 5–10 monocytes per cd T cell in the
presence of 10 nM synthetic, i.e. LPS-free HMB-PP [14], with no
additional stimuli. Monocytes incubated with cd T cells or HMB-
PP alone served as controls. In transwell experiments, monocytes
were separated from monocyte-cd T cell co-cultures by 0.4 mm
pore polycarbonate membranes (Fisher Scientific). Alternatively,
monocytes were cultured with 10 ng/ml IFN-c, 20 ng/ml TNF-a,
50 ng/ml GM-CSF, 50 ng/ml M-CSF, 10 ng/ml IL-1b, 10 ng/
ml IL-4, or 50 ng/ml IL-6 (Peprotech); 100 ng/ml trimeric
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CD40L with 1 mg/ml enhancer (Alexis); 100 ng/ml LPS from
Salmonella abortus equii (Sigma); 5 mg/ml PGN from Staphylococcus
aureus (Sigma); or combinations of which. Blocking reagents used
were anti-IFN-c (25718), anti-GM-CSF (3209), anti-IL-4 (3007),
and anti-CD40L (40804) from R&D Systems; anti-CD11a (TS1/
22), anti-CD11b (OKM1), and anti-CD18 (TS1/18) from Dr. R.
Pardi (DIBIT-Scientific Institute San Raffaele, Milano, Italy); anti-
CD49d (HP2/1, HP2/11) from Dr. F. Sa´nchez-Madrid (Hospital
Universitario de la Princesa, Madrid, Spain); and sTNFR p75-
IgG1 fusion protein (etanercept, EnbrelH) from Amgen; alone or in
combination at 10 mg/ml each.
APC assays
Monocytes were activated as described above except that the
co-cultured cd T cells were irradiated at 12–19 Gray. Freshly
isolated or pre-activated monocytes were washed and used as
APCs for autologous bulk TCRab+ T cells or naı¨ve CD4+ T cells,
at a ratio of 5–10 ab T cells per monocyte; for proliferation assays,
responder ab T cells were pre-labeled with CFSE (Molecular
Probes). TSST-1 (Toxin Technology) was pulsed directly onto
APCs at 1 ng/ml for 1 h; PPD (Statens Serum Institut) was added
to the T cell cultures at 1 mg/ml.
Microscopic analysis
Monocytes were co-cultured with cd T cells as described above
except that in some assays cd T cells were purified using
biotinylated pan-TCRcd mAbs (11F2; BD Biosciences) and anti-
biotin microbeads (Miltenyi), and labeled with PKH26 (Sigma).
Photographs were taken from live cultures at a magnification of
2006, using a Leica DM IRBE inverted microscope with a
Hamamatsu ORCA-ER camera supported with OpenLab 3.1.7
(Improvision). Images were processed with Photoshop 6.0 (Adobe).
Real-time PCR
cd T cells and monocytes from 4.5–6 hours co-cultures with or
without HMB-PP were sorted to .99.5% purity each on a MoFlo
machine (Cytomation), using mAbs against Vc9, Vd2, CD3, CD4,
and CD14. Freshly isolated cd T cells and monocytes served as
controls. Total RNA was isolated using Trizol (Invitrogen) and
reverse transcribed with SuperScript II in the presence of 500 mg/
ml random hexamer primers and 100 mM dNTPs (Invitrogen).
Real-time PCRs were run on ABI Prism 7000 and 7900HT
systems, using 26ABI master mix (Applied Biosystems), 0.9 mM
forward and reverse primers, and 0.25 mM 59-FAM and 39-BHQ1
labeled probes (Microsynth). Primer sequences are listed in Table
S4; amplification efficiencies were between 1.92 and 2.0
(R2.0.95). Relative gene quantification was performed in
duplicate using the 22DDCT method. Results were expressed as
expression levels relative to 1,000 copies of cyclophilin A.
Culture supernatants and effluent samples
Cell-free peritoneal effluents and culture supernatants were
analyzed using ELISA kits for IL-1b, IL-6, IL-12p70, IL-17, IL-27,
CXCL10, TRAIL, and OSM (R&D Systems); IFN-c, TNF-a,
CXCL8, and CCL2 (BD Biosciences); and IL-23 (eBioscience).
Monocyte-derived nitric oxide was assessed using the Total Nitric
Oxide and Nitrate/Nitrite Parameter Assay Kit (R&D Systems). All
samples were measured in duplicate on a Dynex MRX II reader.
Statistical analysis
Data were analyzed using two-tailed Student’s t-tests (GraphPad
Prism 4.0), with differences considered significant as indicated in
the figures: *, p,0.05; **, p,0.01; ***, p,0.001.
Supporting Information
Table S1 Schematic summary of the phenotypical character-
ization of freshly isolated monocytes, monocytes cultured in
medium or with LPS, recombinant GM-CSF+IL 4, M-CSF, or
IFN-c+TNF-a, and monocytes cultured in the presence of cd T
cells+HMB-PP, based on up to 17 independently assessed donors.
Expression levels of the markers indicated were assessed after
18 hours of stimulation: 2, absent or marginal; +, present; ++,
strongly expressed; +++, very strongly expressed; n.d., not
determined.
Found at: doi:10.1371/journal.ppat.1000308.s001 (0.02 MB PDF)
Table S2 Peritoneal dialysis patients with and without acute
bacterial peritonitis that were analyzed in this study. n.a., not
applicable.
Found at: doi:10.1371/journal.ppat.1000308.s002 (0.02 MB PDF)
Table S3 Distribution across bacterial genomes of coding
sequences for 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) re-
ductase (hmgr), the key enzyme of the classical mevalonate
pathway; and for HMB-PP synthase (ispG) and HMB-PP reductase
(ispH), two enzymes of the alternative non-mevalonate pathway of
isoprenoid synthesis. Genomic and protein sequences from
bacterial species of relevance for the present study were retrieved
from the public servers at the National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov), Wellcome Trust
Sanger Centre (http://www.sanger.ac.uk), Washington University
Genome Sequencing Center (http://genome.wustl.edu), and
Baylor College of Medicine Human Genome Sequencing Center
(http://www.hgsc.bcm.tmc.edu). Sequence homologies were ana-
lyzed by TBLASTN searches, using the corresponding sequences
from E. coli, Listeria monocytogenes, and Staphylococcus aureus as
templates.
Found at: doi:10.1371/journal.ppat.1000308.s003 (0.03 MB PDF)
Table S4 Primer sequences for real-time PCR analysis.
Found at: doi:10.1371/journal.ppat.1000308.s004 (0.02 MB PDF)
Figure S1 cd T cells promote monocyte survival. (A–B)
Microscopic analysis of monocytes cultured for 18 hours under
the conditions indicated, representative of three individual donors.
cd T cells in B were pre-labeled with PKH26 and are visualized in
red; for HMB-PP treated cells three typical co-culture images are
shown.
Found at: doi:10.1371/journal.ppat.1000308.s005 (0.32 MB PDF)
Figure S2 Monocyte-cd T cell crosstalk depends on soluble
mediators. (A) MFI of CD14 and CD40 for monocytes after
18 hours of culture in medium alone or with GM-CSF+IL-4, and
for monocytes separated from monocyte-cd T cell co-cultures
without or with HMB-PP and anti-IFN-c+sTNFR (data from two
individual donors). (B) Microscopic analysis of monocytes and cd
T cells co-cultured for 18 hours in the presence of HMB-PP and
the blocking reagents indicated. Data shown are representative of
two individual donors.
Found at: doi:10.1371/journal.ppat.1000308.s006 (0.22 MB PDF)
Figure S3 Acquisition of APC markers by cd T cell-activated
monocytes depends in part on IFN-c, TNF-a, GM-CSF, and IL-4.
MFI6SEM of CD14, CD40, CD86, and HLA-DR for monocytes
after 18 hours of culture under the conditions indicated (n= 4–8).
Found at: doi:10.1371/journal.ppat.1000308.s007 (0.02 MB PDF)
Figure S4 cd T cell-activated monocytes express DC markers.
(A) Side scatter and CD209 fluorescence for monocytes after
18 hours of culture under the conditions indicated. Results are
representative of four independently assessed donors; numbers
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indicate the percentage of CD209+ monocytes. (B) MFI6SEM of
CD83, CD206, and CD209 for monocytes after 18 hours of
culture under the conditions indicated (n= 4–10).
Found at: doi:10.1371/journal.ppat.1000308.s008 (0.05 MB PDF)
Figure S5 Peritoneal cd T cells respond to HMB-PP and
promote monocytes differentiation. 250,000 peritoneal cells were
cultured with HMB-PP at the indicated concentrations. (A)
Microscopic analysis of cultures after 18 hours in the absence or
presence of 100 nM HMB-PP and the blocking reagents indicated.
(B) cd T cell responses are shown as % of Vc 9+ T cells expressing
surface CD25 and CD69, and intracellular TNF-a, and as % of
Vc 9+ among all CD3+ T cells after 7 days. (C) Monocyte
responses are shown as forward scatter; MFI of CD14, CD40,
CD86, and TRAIL; and percentage of TNF-a+ monocytes after
18 h.
Found at: doi:10.1371/journal.ppat.1000308.s009 (0.37 MB PDF)
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